跳至主要内容
临床试验/JPRN-UMIN000006882
JPRN-UMIN000006882已完成4 期

Evaluation of Concomitant Adalimumab and Cytapheresis in Patients who lose Response to Adalimumab Therapy - Supplement cytapheresis improve response of adalimumab; SAPPHIRE study

Department of Lower Gastroenterology, Hyogo College of Medicine0 个研究点目标入组 20 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Cases that are contraindicated for GMA Granulocyte count below 2000/mm3 Complication by infection present or suspected (2) Patients with small intestine type Crohn's disease (no large bowel lesion) (3) Patients with colostomy (4) Patients younger than 15 (5) Patients who do not submit informed consent (6) Patients with malignant tumor (7) Patients within 3 months of post intestinal surgery (8) Patients with short bowel syndrome (9) Other patients judged as inappropriate by the physician

研究者

发起方
Department of Lower Gastroenterology, Hyogo College of Medicine

相似试验

Evaluation of Concomitant Adalimumab and... | 临床试验